Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Clinical trial NCT02245568 · TERMINATED
Trial details
- NCT number
- NCT02245568
- Sponsor
- TauRx Therapeutics Ltd
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2017-05-01
- Enrollment
- 913
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.